When depression persists despite several medication trials, it can feel like your brain is not responding the way it should. You may be doing the work, showing up to appointments, and still not feeling meaningful relief. In our psychiatrist-led, adult and adolescent practice, our job is to help you move from frustration to a plan that is structured and realistic.
SPRAVATO® is not a traditional daily antidepressant. It is an in-office esketamine nasal spray treatment delivered under a required safety program, and it is designed for adults. We can also help you explore other evidence-based options when teens need a higher level of depression support. Contact us today to learn more about how SPRAVATO® works and if it is right for you.
Most antidepressants target serotonin, norepinephrine, or dopamine systems and can take weeks to build effect. SPRAVATO® therapy is different because it acts on the brain’s glutamate pathways.
For you, this difference matters because it may be an option when standard medication strategies have not delivered the improvement you need. Your psychiatrist will still review the full picture, including diagnosis, co-occurring conditions like anxiety or bipolar disorder, and attention symptoms, since those details are important when creating the safest and most effective plan.
Because esketamine nasal spray is administered in a medical setting, the experience is more structured than picking up a prescription. While each person’s SPRAVATO® plan is individualized, many people follow a pattern that starts with more frequent dosing and transitions to maintenance based on response, allowing our team to monitor how the therapy works for you.
A typical in-office esketamine visit includes:
We will also talk with you about what you might feel during the visit, such as temporary sleepiness or a sense of detachment, so you can plan for comfort and support. The monitoring requirement is part of the FDA-approved safety framework and the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) program.
SPRAVATO® is indicated for treatment-resistant depression in adults, and it is also indicated for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior when used with an oral antidepressant. Even so, the most important question is whether it fits your specific clinical situation.
In your evaluation, we will:
This process helps you feel informed rather than rushed. It also helps ensure that procedure-based depression care is paired with the ongoing psychiatric follow-through that makes treatment sustainable.
If you are considering an advanced option for depression, understanding the structure of treatment can ease a lot of uncertainty. We will walk you through candidacy, what a monitored dosing day looks like, and how we will measure improvement over time.
Contact us to discuss next steps and learn how SPRAVATO® works in the context of your personal history, so you can move forward with a plan that feels supported and clear.